Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, today announced the appointment of Randy Pritchard as its new Chief Executive Officer, effective immediately. Pritchard brings nearly 25 years of experience in medical device and health technology, including leadership in driving commercial success, innovation, and strategic opportunities
Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, announced today that the National Institutes of Health’s (NIH) Pelvic Floor Disorders Network (PFDN) will include the Leva® Pelvic Health System in a multi-center clinical study
Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, announced today that a new published study adds additional real-world evidence supporting women’s effective use of the Leva® Pelvic Health System to access pelvic floor muscle training (PFMT), which is first-line treatment for incontinence.
Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, has closed on an additional $9.4 million in its Series A fundraising.
Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, unveiled the findings from a landmark study to understand the impact of urinary incontinence (UI) on women in sub-Saharan Africa.
Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, welcomes the Centers for Medicare & Medicaid Services’ (CMS) new Healthcare Common Procedure Coding System (HCPCS) Level II code for the Leva® Pelvic Health System.
Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, announced today that leading pelvic health researchers have published a new study demonstrating the Leva® Pelvic Health System’s long-term treatment efficacy for female urinary incontinence (UI).
Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, has launched a study to examine the barriers women faced while seeking treatment for urinary incontinence (UI) and fecal incontinence (FI).
Axena Health, Inc. (Axena Health), a women’s health medical device company focused on scalable treatments for female pelvic health, congratulates the researchers who received “Best Overall Abstract Presentation” from the International Urogynecological Association (IUGA) at its annual meeting in The Hague / The Netherlands on June 21-24, 2023
Axena Health, Inc. (Axena Health), a FemTech medical device company focused on scalable treatments for female pelvic health, introduced today the Leva® Pelvic Health System for the first-line treatment of chronic fecal incontinence (FI), also called accidental bowel leakage (ABL), in women.
Read this recent editorial where our Chief Medical Officer, Dr. Samantha Pulliam, urges the people and organizations that provide care for women to help #reducetheshame of incontinence so that more women share their symptoms and access effective treatment.
The theme of this year’s annual National Women’s Health Week is ‘Women’s Health, Whole Health: Prevention, Care, and Wellbeing’.
Axena Health stands with the Office on Women’s Health in calling for everyone to help support women and girls in reflecting on their health and taking steps to prioritize, improve and maintain their overall health.
